ALCON INC (2U3.DE) Stock Fundamental Analysis
Europe - FRA:2U3 - CH0432492467 - Common Stock
64.86 EUR
0 (0%)
Taking everything into account, 2U3 scores 5 out of 10 in our fundamental rating. 2U3 was compared to 62 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of 2U3 get a neutral evaluation. Nothing too spectacular is happening here. 2U3 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year 2U3 was profitable.
2U3 had a positive operating cash flow in the past year.
2U3 had positive earnings in 4 of the past 5 years.
In the past 5 years 2U3 always reported a positive cash flow from operatings.
1.2 Ratios
2U3 has a Return On Assets of 3.42%. This is comparable to the rest of the industry: 2U3 outperforms 50.00% of its industry peers.
2U3 has a Return On Equity (4.85%) which is comparable to the rest of the industry.
2U3's Return On Invested Capital of 3.87% is on the low side compared to the rest of the industry. 2U3 is outperformed by 62.90% of its industry peers.
2U3 had an Average Return On Invested Capital over the past 3 years of 3.01%. This is significantly below the industry average of 8.76%.
The last Return On Invested Capital (3.87%) for 2U3 is above the 3 year average (3.01%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.42% | ||
| ROE | 4.85% | ||
| ROIC | 3.87% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
1.3 Margins
The Profit Margin of 2U3 (10.70%) is better than 66.13% of its industry peers.
2U3's Profit Margin has improved in the last couple of years.
2U3 has a Operating Margin of 13.81%. This is in the better half of the industry: 2U3 outperforms 64.52% of its industry peers.
In the last couple of years the Operating Margin of 2U3 has grown nicely.
2U3's Gross Margin of 54.26% is in line compared to the rest of the industry. 2U3 outperforms 46.77% of its industry peers.
2U3's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.81% | ||
| PM (TTM) | 10.7% | ||
| GM | 54.26% |
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 2U3 is destroying value.
The number of shares outstanding for 2U3 has been increased compared to 1 year ago.
2U3 has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 2U3 has been reduced compared to a year ago.
2.2 Solvency
2U3 has an Altman-Z score of 4.04. This indicates that 2U3 is financially healthy and has little risk of bankruptcy at the moment.
2U3's Altman-Z score of 4.04 is fine compared to the rest of the industry. 2U3 outperforms 64.52% of its industry peers.
2U3 has a debt to FCF ratio of 3.71. This is a good value and a sign of high solvency as 2U3 would need 3.71 years to pay back of all of its debts.
The Debt to FCF ratio of 2U3 (3.71) is better than 67.74% of its industry peers.
2U3 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
2U3 has a Debt to Equity ratio of 0.23. This is in the better half of the industry: 2U3 outperforms 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.71 | ||
| Altman-Z | 4.04 |
ROIC/WACC0.83
WACC4.69%
2.3 Liquidity
A Current Ratio of 2.60 indicates that 2U3 has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.60, 2U3 is doing good in the industry, outperforming 69.35% of the companies in the same industry.
A Quick Ratio of 1.61 indicates that 2U3 should not have too much problems paying its short term obligations.
The Quick ratio of 2U3 (1.61) is better than 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 5.23% over the past year.
Measured over the past years, 2U3 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.04% on average per year.
2U3 shows a small growth in Revenue. In the last year, the Revenue has grown by 4.04%.
The Revenue has been growing slightly by 5.71% on average over the past years.
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
3.2 Future
Based on estimates for the next years, 2U3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.63% on average per year.
Based on estimates for the next years, 2U3 will show a small growth in Revenue. The Revenue will grow by 6.30% on average per year.
EPS Next Y1.29%
EPS Next 2Y7.54%
EPS Next 3Y10.27%
EPS Next 5Y11.63%
Revenue Next Year5.35%
Revenue Next 2Y6.52%
Revenue Next 3Y6.66%
Revenue Next 5Y6.3%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
2U3 is valuated quite expensively with a Price/Earnings ratio of 25.04.
72.58% of the companies in the same industry are more expensive than 2U3, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.83, 2U3 is valued at the same level.
With a Price/Forward Earnings ratio of 21.40, 2U3 is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 2U3 is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.88, 2U3 is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.04 | ||
| Fwd PE | 21.4 |
4.2 Price Multiples
61.29% of the companies in the same industry are more expensive than 2U3, based on the Enterprise Value to EBITDA ratio.
2U3's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 2U3 is cheaper than 72.58% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.66 | ||
| EV/EBITDA | 15.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
2U3 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)19.4
PEG (5Y)2.49
EPS Next 2Y7.54%
EPS Next 3Y10.27%
5. Dividend
5.1 Amount
2U3 has a yearly dividend return of 0.46%, which is pretty low.
Compared to an average industry Dividend Yield of 2.23, 2U3 has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.30, 2U3's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
15.47% of the earnings are spent on dividend by 2U3. This is a low number and sustainable payout ratio.
DP15.47%
EPS Next 2Y7.54%
EPS Next 3Y10.27%
FRA:2U3 (10/27/2025, 7:00:00 PM)
64.86
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners69.85%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap32.41B
Revenue(TTM)10.03B
Net Income(TTM)1.07B
Analysts80
Price Target92.52 (42.65%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.46% |
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP15.47%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.12%
Min EPS beat(2)-4.26%
Max EPS beat(2)4.49%
EPS beat(4)3
Avg EPS beat(4)2.12%
Min EPS beat(4)-4.26%
Max EPS beat(4)7.68%
EPS beat(8)6
Avg EPS beat(8)1.75%
EPS beat(12)8
Avg EPS beat(12)2.4%
EPS beat(16)12
Avg EPS beat(16)4.71%
Revenue beat(2)0
Avg Revenue beat(2)-3.2%
Min Revenue beat(2)-3.43%
Max Revenue beat(2)-2.97%
Revenue beat(4)0
Avg Revenue beat(4)-2.13%
Min Revenue beat(4)-3.43%
Max Revenue beat(4)-0.56%
Revenue beat(8)0
Avg Revenue beat(8)-1.84%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)5
Avg Revenue beat(16)-0.17%
PT rev (1m)0.15%
PT rev (3m)-4.84%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)-3.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.23%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.04 | ||
| Fwd PE | 21.4 | ||
| P/S | 3.76 | ||
| P/FCF | 26.66 | ||
| P/OCF | 18.01 | ||
| P/B | 1.71 | ||
| P/tB | 10.09 | ||
| EV/EBITDA | 15.52 |
EPS(TTM)2.59
EY3.99%
EPS(NY)3.03
Fwd EY4.67%
FCF(TTM)2.43
FCFY3.75%
OCF(TTM)3.6
OCFY5.55%
SpS17.24
BVpS38.02
TBVpS6.43
PEG (NY)19.4
PEG (5Y)2.49
Graham Number47.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.42% | ||
| ROE | 4.85% | ||
| ROCE | 4.78% | ||
| ROIC | 3.87% | ||
| ROICexc | 4.07% | ||
| ROICexgc | 12.21% | ||
| OM | 13.81% | ||
| PM (TTM) | 10.7% | ||
| GM | 54.26% | ||
| FCFM | 14.11% |
ROA(3y)2.6%
ROA(5y)1.44%
ROE(3y)3.72%
ROE(5y)2.06%
ROIC(3y)3.01%
ROIC(5y)N/A
ROICexc(3y)3.18%
ROICexc(5y)N/A
ROICexgc(3y)10.24%
ROICexgc(5y)N/A
ROCE(3y)3.72%
ROCE(5y)N/A
ROICexgc growth 3Y2.95%
ROICexgc growth 5Y30.08%
ROICexc growth 3Y10.31%
ROICexc growth 5Y41.26%
OM growth 3Y6.79%
OM growth 5Y35.45%
PM growth 3Y31.33%
PM growth 5YN/A
GM growth 3Y-0.59%
GM growth 5Y2.7%
F-Score5
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 3.71 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 52.59% | ||
| Cap/Sales | 6.78% | ||
| Interest Coverage | 7.52 | ||
| Cash Conversion | 78.26% | ||
| Profit Quality | 131.87% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 4.04 |
F-Score5
WACC4.69%
ROIC/WACC0.83
Cap/Depr(3y)77.98%
Cap/Depr(5y)73.14%
Cap/Sales(3y)9.96%
Cap/Sales(5y)10.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.23%
EPS 3Y12.36%
EPS 5Y10.04%
EPS Q2Q%2.7%
EPS Next Y1.29%
EPS Next 2Y7.54%
EPS Next 3Y10.27%
EPS Next 5Y11.63%
Revenue 1Y (TTM)4.04%
Revenue growth 3Y6.13%
Revenue growth 5Y5.71%
Sales Q2Q%3.25%
Revenue Next Year5.35%
Revenue Next 2Y6.52%
Revenue Next 3Y6.66%
Revenue Next 5Y6.3%
EBIT growth 1Y9.67%
EBIT growth 3Y13.34%
EBIT growth 5Y43.18%
EBIT Next Year35.35%
EBIT Next 3Y18.66%
EBIT Next 5Y15.03%
FCF growth 1Y346.37%
FCF growth 3Y104.3%
FCF growth 5Y41.96%
OCF growth 1Y81.07%
OCF growth 3Y15.59%
OCF growth 5Y17.69%
ALCON INC / 2U3.DE FAQ
What is the ChartMill fundamental rating of ALCON INC (2U3.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 2U3.DE.
Can you provide the valuation status for ALCON INC?
ChartMill assigns a valuation rating of 4 / 10 to ALCON INC (2U3.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALCON INC?
ALCON INC (2U3.DE) has a profitability rating of 6 / 10.
Can you provide the financial health for 2U3 stock?
The financial health rating of ALCON INC (2U3.DE) is 6 / 10.
Is the dividend of ALCON INC sustainable?
The dividend rating of ALCON INC (2U3.DE) is 2 / 10 and the dividend payout ratio is 15.47%.